Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002838/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Determine the efficacy,safety, and tolerability of BG00012 in MS patients.
评估BG00012在多发性硬化（Multiple Sclerosis, MS）患者中的疗效、安全性与耐受性
提供机构：
Vivli
创建时间：
2018-10-27
